Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oliceridine vs sufentanil for postoperative analgesia after lumbar posterior fusion
ChiCTR2500101994Phase 4Not yet recruiting
- Sponsor
- Wuhan Tongji Modern Pharmaceutical Technology
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of oliceridine in Herniated Lumbar Disk (3 arms), sponsored by Wuhan Tongji Modern Pharmaceutical Technology. Primary endpoints: Numeric Rating Scale (NRS) pain score at 12 hours after surgery, Bruggrmann comfort scale (BCS) at 12 hours after surgery and 2 more. Planned start May 2025; status: not yet recruiting.
02
Drugs
oliceridine
03
Conditions
Herniated Lumbar Disk
Beyond the preview
Go deeper on ChiCTR2500101994.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500101994.